MX9200571A - Actividad de anti-reactiva antiasmatica de los farmacos anti-inflamatorios no esteroidales por inhalacion. - Google Patents
Actividad de anti-reactiva antiasmatica de los farmacos anti-inflamatorios no esteroidales por inhalacion.Info
- Publication number
- MX9200571A MX9200571A MX9200571A MX9200571A MX9200571A MX 9200571 A MX9200571 A MX 9200571A MX 9200571 A MX9200571 A MX 9200571A MX 9200571 A MX9200571 A MX 9200571A MX 9200571 A MX9200571 A MX 9200571A
- Authority
- MX
- Mexico
- Prior art keywords
- inhalation
- inflammatory drugs
- asthmatic
- drugs
- steroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91101818 | 1991-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200571A true MX9200571A (es) | 1992-12-01 |
Family
ID=8206393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200571A MX9200571A (es) | 1991-02-09 | 1992-02-10 | Actividad de anti-reactiva antiasmatica de los farmacos anti-inflamatorios no esteroidales por inhalacion. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6051566A (es) |
| JP (1) | JPH0648958A (es) |
| KR (1) | KR920016086A (es) |
| AT (1) | ATE179605T1 (es) |
| AU (1) | AU662509B2 (es) |
| BR (1) | BR9200429A (es) |
| CA (1) | CA2060937A1 (es) |
| CZ (1) | CZ281970B6 (es) |
| DE (1) | DE69229070T2 (es) |
| HU (1) | HUT60917A (es) |
| IE (1) | IE920427A1 (es) |
| IL (1) | IL100896A (es) |
| MX (1) | MX9200571A (es) |
| NO (1) | NO179893C (es) |
| NZ (1) | NZ241542A (es) |
| ZA (1) | ZA92890B (es) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| TWI290473B (en) | 2000-05-10 | 2007-12-01 | Alliance Pharma | Phospholipid-based powders for drug delivery |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US7256184B2 (en) * | 2000-10-16 | 2007-08-14 | Rodriguez Victorio C | Treatment of aging disorders in humans |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| WO2002094246A2 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| US6759029B2 (en) * | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
| US6805853B2 (en) * | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
| ATE415155T1 (de) * | 2001-05-24 | 2008-12-15 | Alexza Pharmaceuticals Inc | Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation |
| AU2002352726A1 (en) | 2001-11-15 | 2003-06-10 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
| WO2003057188A1 (en) * | 2001-11-21 | 2003-07-17 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| PT1458360E (pt) | 2001-12-19 | 2011-07-13 | Novartis Ag | Derivados de indole como agonistas do recetor s1p1 |
| US8003080B2 (en) | 2002-05-13 | 2011-08-23 | Alexza Pharmaceuticals, Inc. | Delivery of drug amines through an inhalation route |
| US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
| US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| AU2003294470B2 (en) * | 2002-11-26 | 2009-09-17 | Alexza Pharmaceuticals, Inc. | Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| WO2004047841A1 (en) * | 2002-11-26 | 2004-06-10 | Alexza Molecular Delivery Corporation | Treatment of headache with antipsychotics delivered by inhalation |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| US20040234699A1 (en) | 2003-05-21 | 2004-11-25 | Alexza Molecular Delivery Corporation | Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| US8455437B2 (en) * | 2005-02-04 | 2013-06-04 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Method to predict and prevent oxygen-induced inflammatory tissue injury |
| ITMI20050417A1 (it) * | 2005-03-15 | 2006-09-16 | Medestea Res & Production S R L | Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica |
| US20070203104A1 (en) * | 2006-02-09 | 2007-08-30 | Chaudhry Saeed M | Pharmaceutical Formulations |
| JP5094197B2 (ja) * | 2006-04-27 | 2012-12-12 | 第一三共ヘルスケア株式会社 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| DE102008004386A1 (de) * | 2008-01-14 | 2009-07-23 | Activaero Gmbh | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
| CA2722668A1 (en) * | 2008-04-29 | 2009-11-05 | Wyeth Llc | Methods for treating inflammation |
| KR101704815B1 (ko) * | 2009-08-21 | 2017-02-09 | 포항공과대학교 산학협력단 | Ｉｌ－１７ 매개 염증질환의 치료를 위한 조합 제제 및 이를 이용한 치료 방법 |
| US20130281405A1 (en) * | 2012-04-02 | 2013-10-24 | Lenard M. Lichtenberger | Use of pc-nsaids to treat and/or prevent pulmonary inflammation |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| EP2991634A1 (en) * | 2013-04-30 | 2016-03-09 | Otitopic Inc. | Dry powder formulations and methods of use |
| TWI586383B (zh) * | 2014-04-18 | 2017-06-11 | 林信湧 | 一種用於治療關節炎之吸入式醫藥組成物及其備製方法 |
| WO2016040570A2 (en) | 2014-09-12 | 2016-03-17 | Children's Medical Center Corporation | Dietary emulsion formulations and methods for using the same |
| US11723864B2 (en) * | 2015-05-29 | 2023-08-15 | The Texas A&M University System | Antimicrobial and anti-inflammatory compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244899A (en) * | 1985-02-04 | 1993-09-14 | G. D. Searle And Co. | Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders |
| US4885287A (en) * | 1988-08-09 | 1989-12-05 | University Of Kentucky Research Foundation | Novel method of administering aspirin and dosage forms containing same |
-
1992
- 1992-02-06 AT AT92101977T patent/ATE179605T1/de not_active IP Right Cessation
- 1992-02-06 DE DE69229070T patent/DE69229070T2/de not_active Expired - Lifetime
- 1992-02-07 NZ NZ241542A patent/NZ241542A/en unknown
- 1992-02-07 IE IE042792A patent/IE920427A1/en unknown
- 1992-02-07 NO NO920504A patent/NO179893C/no unknown
- 1992-02-07 CZ CS92352A patent/CZ281970B6/cs unknown
- 1992-02-07 BR BR929200429A patent/BR9200429A/pt not_active Application Discontinuation
- 1992-02-07 ZA ZA92890A patent/ZA92890B/xx unknown
- 1992-02-07 AU AU10772/92A patent/AU662509B2/en not_active Ceased
- 1992-02-07 KR KR1019920001737A patent/KR920016086A/ko not_active Application Discontinuation
- 1992-02-07 IL IL100896A patent/IL100896A/en not_active IP Right Cessation
- 1992-02-07 JP JP4056158A patent/JPH0648958A/ja active Pending
- 1992-02-07 HU HU9200389A patent/HUT60917A/hu unknown
- 1992-02-10 MX MX9200571A patent/MX9200571A/es unknown
- 1992-02-10 CA CA002060937A patent/CA2060937A1/en not_active Abandoned
-
1998
- 1998-03-02 US US09/032,973 patent/US6051566A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU662509B2 (en) | 1995-09-07 |
| NO179893B (no) | 1996-09-30 |
| NO920504D0 (no) | 1992-02-07 |
| CZ281970B6 (cs) | 1997-04-16 |
| IL100896A (en) | 1998-02-22 |
| AU1077292A (en) | 1992-08-13 |
| IE920427A1 (en) | 1992-08-12 |
| CA2060937A1 (en) | 1992-08-10 |
| NO920504L (no) | 1992-08-10 |
| ZA92890B (en) | 1992-12-30 |
| NZ241542A (en) | 1996-05-28 |
| BR9200429A (pt) | 1992-10-13 |
| US6051566A (en) | 2000-04-18 |
| DE69229070D1 (de) | 1999-06-10 |
| JPH0648958A (ja) | 1994-02-22 |
| ATE179605T1 (de) | 1999-05-15 |
| CS35292A3 (en) | 1992-08-12 |
| KR920016086A (ko) | 1992-09-24 |
| HU9200389D0 (en) | 1992-04-28 |
| HUT60917A (en) | 1992-11-30 |
| NO179893C (no) | 1997-01-08 |
| IL100896A0 (en) | 1992-11-15 |
| DE69229070T2 (de) | 1999-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9200571A (es) | Actividad de anti-reactiva antiasmatica de los farmacos anti-inflamatorios no esteroidales por inhalacion. | |
| DE3581819D1 (de) | Pyridazinamine wirksam gegen viren. | |
| IE862554L (en) | Pharmaceutical compositions | |
| DK0771189T3 (da) | Inhalationspræparat | |
| BR9908587A (pt) | Inalador de pó | |
| BR9912694A (pt) | Composto para preparar medicamento de administração pulmonar | |
| NO955227L (no) | Inhaleringspreparater | |
| SE8700498L (sv) | Nya farmakologiskt aktiva foreningar | |
| DE69223914T2 (de) | 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate | |
| SE8305485L (sv) | Galeniska kompositioner innefattande kalcitonin och deras anvendning | |
| MX9300779A (es) | 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas | |
| ITMI930582A1 (it) | Composizione farmeceutiche ad attivita' analgesica | |
| EP0919229A3 (en) | Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation | |
| ES8706651A1 (es) | Un procedimiento para preparar derivados de tetrazol. | |
| JPS57114518A (en) | Hypotensive agent | |
| TH16088A (th) | สูตรผสมสำหรับการสูดดม | |
| DE69325531T2 (de) | Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen | |
| IT8948578A0 (it) | Impiego di farmaci anti-infiammatori non steroidei in generale ed in particolare l'acido tiaprofenico, comunemente chiamati fans, in soluzione per applicazione topica sotto forma di spray, realizzato connebulizzatore senza uso di propellenti gassosi. | |
| TH33149A (th) | สูตรผสมละอองลอยที่เป็นยา | |
| IT9041667A1 (it) | Inalatore per aerosolterapia basato sul sistema "usa e getta" dei due componenti "mascherina per inalazione" e "contenitore portafarmaco". | |
| IT1150451B (it) | Composizione farmaceutica ad attivita'analgesica,antiretica e antiinfiammatoria e procedimento per la preparazione del principio attivo | |
| IT9030691U1 (it) | Inalatore per aerosolterapia basato sul sistema "usa e getta" dei due componenti "mascheria per inalazione " e "contenitore portafarmaco" | |
| ITFI920029V0 (it) | " inalatore per addurre aria da inspirare, per impiego in presenza diatmosfere nocive " | |
| IT8519975A0 (it) | Composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono. | |
| JPS57105423A (en) | Chloroethylureidopropylpolysilsesquioxane |